Tag: OPXA

Blue Horseshoe Stocks: SPHS, OPXA, PPCH Highlights

Sophiris Bio, Inc. SPHS

SPHS was the first mention from yesterday’s morning report to grab our attention with an early surge that provided the chance at a rapid, substantial gain. From the low-of-day at 1.02, the stock made a big move to 1.64; an increase of 60% inside of the first half-hour of the session. The bulk of the day’s volume, which came in at more than 18X the three-month average, traded in that short time-span as well.

In addition to the heavy volume, making its biggest moves early in the trading day seems to be an established pattern with SPHS, so we’ll have an eye peeled as the session commences today.

Opexa Therapeutics, Inc. OPXA

The other standout from yesterday’s report was OPXA, which spiked on word of coverage initiation by large investment banking and research firm, Maxim Group. (>>View PR)

From its daily low of .43, the stock stair-stepped its way up throughout the session and eventually hit a high of .54; an intraday gain of 26% As it appears to gapping up in the premarket and has already touched .58, the total increase we’ve seen gets pushed to 35% We’ll be interested to follow the impending activity as well as check out the CEO’s presentation which we detail below.

Per a news release from last week, “Neil K. Warma, President and Chief Executive Officer, will present at the 2015 Marcum Microcap Conference on Thursday, May 28, 2015, at 11:30 a.m. EDT in the Plymouth Room. The conference will be held at the Grand Hyatt New York Hotel in New York, NY. A live webcast of the company presentation can be accessed here, or via the Investor Relations section of the Company’s website at www.opexatherapeutics.com.

Propanc Health Group Corp. PPCH

PPCH is a stock that we began tracking in the second week of March, and over the period of several weeks since that time the stock has made some truly epic moves. Subsequent to our tag of PPCH on March 18th, we observed a low of .0116, followed by an impressive run up to an even dime. That 762% mega-run was followed by a tapering back to a low of .021.

Yesterday the stock soared almost all the way back to its previous high, touching .094, which marks another swing of 348% that we;ve seen from this incredible mover. If the stock can breach that previous swing-high, it’ll be off to the races, so we’ll definitely keep PPCH an item of interest moving forward.

Extended Watchlist:
BIOC, NETE, OHGI, MNGA

Blue Horseshoe Stocks: ATNM Recap & More

Actinium Pharmaceuticals, Inc. ATNM

In the midst of what has begun as a relatively slow short week, ATNM has stood out as a solid play. We tagged this stock for observation in last Thursday’s report, and the subsequent move has been quite noteworthy.

Entering into the holiday weekend, we had witnessed a low of 2.78, and yesterday the stock jumped to a new high of 4.34. Considering it took just three sessions for the pick to provide, that 56% swing is quite significant.

ATMN is among a wide array of companies that will be appearing at this year’s Marcum Microcap Conference in NYC  For those unable to attend the company will be providing a live webcast of its presentation (05/28 @ 10:30am Eastern) Read the news release for details  >>> VIEW PR

PlasmaTech Biopharma, Inc. PTBI

Speaking of companies presenting at the upcoming Marcum Microcap Conference whose stocks have recently featured in our reports, we’re turning our attention back to PTBI this morning.

We followed the stock to a nice gain opportunity early last week (+35%), and after an interim period of consolidation, we’re seeing a sizable gap-up occurring in this morning’s premarket activity.

As you can see on the chart, PTBI has built toward what is known as a Bullish Flag, which can be an indicator of more gains ahead. We’ll look for the stock to hold support above yesterday’s swing low (8.55) in order to maintain the trend.

Extended Watchlist:
PLUG, SPHS, EOX, OPXA, OXGN, HYGS, CBLI

Blue Horseshoe Stocks: PBR, INO, RAD Reviews & More

Petroleo Brasiliero, S.A. (Petrobras) PBR – Options

PBR has continued to perform this week after we caught it coming off its 52-week lows two Thursday’s ago. At that time one of our main areas of interest was the 05/01 $6.50 Calls, which we subsequently observed trading at a low of .22. This week they’ve attained a high of .71, marking off a tidy 222% move.

The last time we touched upon PBR options on Monday morning, it was in the process of pushing even higher, so we suggested the possibility of rolling up our strike price to  both the Weekly and May 1st $7 Calls, and that idea turned out to be a good one as well.

We’ve witnessed a trading range on the Weekly $7’s from .06 -.25, a whopping 316%, while the May 1st $7’s enjoyed an 87% run from .30 to .56.

Inovio Pharmaceuticals, Inc. INO 

INO stands among those stocks that we have covered the most over the years. An INO tag search of our archives yields no less than 30 results. We re-flagged it in yesterday’s premarket report and the timing was quite fortuitous.

Yesterday morning the company had announced it had been selected as the leader of a $45M DARPA program to develop practical treatments for the Ebola virus. It fueled a continued rise off of recent lows, and this morning’s news could contribute to that as well.  >> READ PR

INO heralded positive results from one of its studies, a DNA-based immunotherapy for the treatment of head and neck cancer. According to the CFO, the “initial data set from Inovio’s first cancer study provides encouraging evidence that we are on an important path to better optimized immunotherapy products.” >> READ PR

We’ll continue to keep watch over INO in the wake of these major developments.

Molycorp, Inc. MCP

MCP started showing up on our scanner back on March 23rd and 24th, when it was trading around .38. It retraced back to its 52-week low of .32 on the 27th.

After reappearing on our extended watchlist yesterday, it has traded as high as .62 in the premarket today; from a low of .484 that’s a 28% move up.

At .62, MCP had shown us a 94% overall move from its ultimate low set just the week before last. With gold and other precious metal prices on the rise again, we’ll continue to track MCP for more potential gain opportunities.

Rite-Aid Corp. RAD

We also wanted to make a quick mention of RAD. We tagged the stock for tracking back on December 4th and on that day we observed the lowest price the stock has traded at since then (5.48).

Since that time the stock has crept (and sometimes leaped) its way up the chart; it broke its 50DMA in early March, and managed break the $9-mark last Thursday, and then again yesterday. At Thursday’s high of 9.07, we had witnessed a total gain of 65%

Wall Street analysts are giving RAD high marks, and the stock is also receiving a 96% Overall “Buy” Rating at BARCHART.COM so we’ll certainly want to keep a close watch on RAD moving forward in the event that it sustains the bullish patterns it has been exhibiting over the past several months.

Extended Watchlist:
EXEL, OPXA, WPCS, MPET, MSTX, SLTD